MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

Por Bayley, Rachel, Blakemore, Daniel, García, Paloma
Publicado no Oncotarget (2018)

Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature

Por Volpe, Giacomo, Walton, David S., Grainger, David E., Ward, Carl, Cauchy, Pierre, Blakemore, Daniel, Coleman, Daniel J. L., Cockerill, Peter N., Garcia, Paloma, Frampton, Jon
Publicado no Sci Rep (2017)

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations

Por Volpe, Giacomo, Cauchy, Pierre, Walton, David S, Ward, Carl, Blakemore, Daniel, Bayley, Rachael, Clarke, Mary L, Schmidt, Luisa, Nerlov, Claus, Garcia, Paloma, Dumon, Stéphanie, Grebien, Florian, Frampton, Jon
Publicado no Life Sci Alliance (2019)